reference/35761738

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35761738

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review\|Research Support, Non-U.S. Gov't\|Research Support, N.I.H., Extramural
issn	2073-4409
issueIdentifier	12
pageRange	1671-
publicationName	Cells
startingPage	1671
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_371e080196ba5dd181b71e591a891f30 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f16fa892d32059fb8a61dc613cfc95fc http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3588bbd818363766a10a510216c4e1f6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation	Roy T, Boateng ST, Uddin MB, Banang-Mbeumi S, Yadav RK, Bock CR, Folahan JT, Siwe-Noundou X, Walker AL, King JA, Buerger C, Huang S, Chamcheu JC. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. Cells. 2023 Jun 20;12(12). PMID: 37371141; PMCID: PMC10297376.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ce6ecb75f4b80babb783f2a70aa7fad http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3927-5664 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7552-5192 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6292816dbaac2c00cc4980855287b6c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07bffed7b038d0be248b479068dbd015 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8667-8351 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c521e52d8730e9a005063b7dae9593a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4185dbc015f6d2e19f818b1e3836603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7441-4167 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3239-1072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9665-7442 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7838-197X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6362f09dd61347a97a71d35348e6e05d
date	2023-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC10297376 https://pubmed.ncbi.nlm.nih.gov/37371141 https://doi.org/10.3390/cells12121671
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40953 https://portal.issn.org/resource/ISSN/2073-4409
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
discusses	http://id.nlm.nih.gov/mesh/M0029501 http://id.nlm.nih.gov/mesh/M0557421 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0543042 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0029863
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8154 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9238 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6847 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9610 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7433 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9007 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6777 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173

Total number of triples: 50.